Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2934 (LINC02934, also known as LOC105369167) is a long intergenic non-coding RNA (lincRNA), meaning it is an RNA transcript longer than 200 nucleotides that does not overlap any protein-coding gene and does not code for proteins itself[1][3][5]. As part of the lincRNA family, it may play roles in regulating gene expression through mechanisms such as chromatin remodeling, transcriptional regulation, and RNA stabilization[1][5][7]. LINC02934 is not currently classified as a therapeutic target, and there are no known drugs, mechanisms of drug action, biomarkers, or safety concerns directly linked to this RNA. While some lincRNAs have established roles in gene regulation and disease, especially cancer, there is no disease association specifically annotated for LINC02934 to date[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2934 (LINC02934).